John Stahl
Partner, US Pricing and Market Access
John Stahl is a Partner with Clarivate’s Commercial Strategy Consulting team and leads the US Pricing and Market Access practice.
John leverages over 20 years of deep healthcare knowledge as well as a broad range of market access and commercialization experience to effectively deliver strategic and actionable insights to biopharmaceutical and medtech clients. John has been with Clarivate for 10+ years, and during this time, he has supported clients with the development of market access landscape assessments, evidence generation and value communication strategies, pricing and contracting strategies, and account engagement strategies and tactics. His experience spans numerous TAs, with a concentration in cell and gene therapy, rare disease, oncology, immunology, and neurology conditions.
Prior to joining Clarivate, John spent over ten years in the pharmaceutical industry working for Johnson & Johnson and Novartis, in a variety of positions of increasing responsibility, including business analytics, business development, sales, marketing, and managed markets.
John graduated from Duke University with a B.A. in Economics and a B.A. in German. He also completed the Certificate program in Markets and Management Studies.
Latest news
Clarivate to Present at the Goldman Sachs Communacopia + Technology Conference on September 11
London, UK – September 4, 2025, Clarivate Plc (NYSE: CLVT), a leading global provider of transformative intelligence, announced today that Jonathan Collins, Executive Vice President and Chief Financial Officer, will…
16th Annual Clarivate Pharmavision India Conference to Address Market Shifts, Innovation and Global Access
2025 event to explore how Indian pharmaceutical companies can capture new growth in generics and biosimilars while navigating competition and regulatory complexities London, U.K. September 1, 2025: Clarivate Plc (NYSE:CLVT),…
